<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="132966">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02104778</url>
  </required_header>
  <id_info>
    <org_study_id>apsj20140401</org_study_id>
    <nct_id>NCT02104778</nct_id>
  </id_info>
  <brief_title>Effect of Dexamethasone and Epinephrine on the Duration of Sciatic Nerve Blocks With Ropivacaine</brief_title>
  <official_title>Effect of Dexamethasone and Epinephrine on the Duration of Sciatic Nerve Blocks With Ropivacaine in Ankle and Foot Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yeungnam University College of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yeungnam University College of Medicine</source>
  <oversight_info>
    <authority>Korea: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the present study is to test that adding dexamethasone or epinephrine
      significantly prolongs the duration of sciatic nerve blocks with ropivacaine and that the
      magnitude of the effect differs among dexamethasone and epinehrine.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In a double-blinded trial utilizing single-injection sciatic nerve block, patients are
      randomly assigned to one of three groups: control: 0.5% ropivacaine adding normal saline;
      epinephrine: 0.5% ropivacaine adding epinephrine; dexamethasone: 0.5% ropivacaine adding
      dexamethasone. We assess time to first analgesic request after post-anaesthesia care unit
      discharge.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">July 2015</completion_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>time to first analgesic request after postanesthetic care unit discharge</measure>
    <time_frame>from arrival in postanesthetic care unit to 72 hours after operation</time_frame>
    <safety_issue>No</safety_issue>
    <description>A blinded observer interview patients at arrival in postanesthetic care unit, 6 hour, 24 hour, 48 hour, 72 hour after operation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>time of recovery of motor and sensory functions on the operated foot</measure>
    <time_frame>from arrival in postanesthetic care unit to 72 hours after operation</time_frame>
    <safety_issue>No</safety_issue>
    <description>The time of recovery of motor (ability to move the ankle) and sensory (recovery of normal pinprick sensation) functions on the operated foot is recorded by the blinded observer at arrival in postanesthetic care unit, 6 hour, 24 hour, 48 hour, 72 hour after operation.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Dexamethasone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dexamethasone 8 mg is added to 0.5% ropivacaine 20 ml for sciatic nerve block.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Normal saline 1 ml is added to 0.5% ropivacaine 20 ml for sciatic nerve block.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>epinephrine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Epinephrine 1:200,000 is added to 0.5% ropivacaine 20 ml for sciatic nerve block.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <description>In dexamethasone group, dexamethasone 8 mg is added to 0.5% ropivacaine 20 ml for sciatic nerve block.</description>
    <arm_group_label>Dexamethasone</arm_group_label>
    <other_name>Dexamethasone</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Epinephrine</intervention_name>
    <description>Epinephrine 1:200,000 is added to 0.5% ropivacaine 20 ml for sciatic nerve block</description>
    <arm_group_label>epinephrine</arm_group_label>
    <other_name>epinephrine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiologists physical status I and II

          -  patients undergoing elective hallux valgus repair

        Exclusion Criteria:

          -  patients receiving chronic analgesic therapy

          -  diabetes

          -  peripheral neuropathies

          -  psychiatric disorders

          -  hypersensitivity to amide local anesthetics

          -  renal disorders
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sangjin Park, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anesthesiology and Pain Medicine, College of medicine, Yeungnam University, Daemyung-Dong, Nam-Gu, Daegu, Republic of Korea</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sangjin Park, M.D.</last_name>
    <phone>82-53-620-3366</phone>
    <email>apsj0718@naver.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Anesthesiology and Pain Medicine, Yeungnam University hospital</name>
      <address>
        <city>Daegu</city>
        <zip>705-035</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Duckhee Lee, M.D.</last_name>
      <phone>82-53-620-3365</phone>
      <email>apsj0718@naver.com</email>
    </contact>
    <investigator>
      <last_name>Sangjin Park, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 3, 2014</lastchanged_date>
  <firstreceived_date>April 1, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Yeungnam University College of Medicine</investigator_affiliation>
    <investigator_full_name>Sangjin Park</investigator_full_name>
    <investigator_title>assistant professor</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone 21-phosphate</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
